The head of the FDA faced bipartisan fury from lawmakers over months of delays investigating problems at the nation's largest baby formula plant.
The first batch of imported baby formula under "Operation Fly Formula" arrived in the United States on Sunday as the Biden administration tries to alleviate the nationwide baby formula shortage.
FDA staff began honing in on Abbott's plant last fall while tracking several bacterial infections in infants who had consumed formula from the facility. The four cases occurred between September and January, leading to hospitalization and two deaths. Abbott and the FDA have reached an agreement to reopen the plant next week, under which the company must regularly undergo outside safety audits.
Senior FDA officials eventually received the complaint via email, but not until February due to"an isolated failure in FDA's mailroom, likely due to COVID-19 staffing issues," according to the FDA testimony. A mailed copy addressed to then-acting commissioner Dr. Janet Woodcock has still not been located.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA chief: COVID, mail mix-up delayed action on baby formulaThe head of the Food and Drug Administration is testifying about a series of setbacks that led to a months-long delay in inspecting the plant at the center of a nationwide baby formula shortage
Weiterlesen »
FDA says senior officials didn’t receive infant formula whistleblower report due to 'mailroom issues'The agency's leaders are testifying before a House committee looking into its response to a formula recall that exacerbated shortages.
Weiterlesen »
FDA Chief to Detail Why Inspection of Baby Formula Plant Was DelayedThe head of the Food and Drug Administration is preparing to tell lawmakers about events that led to a months-long gap before inspecting the plant at the center of a nationwide baby formula shortage.
Weiterlesen »
Colorado Congresswoman Diana DeGette To Grill Baby Formula Manufacturers, FDA Over ShortageColorado Congresswoman Diana DeGette is leading a federal inquiry into the nation's baby formula shortage. DeGette is the Chair of the House Energy and Commerce Committee's Oversight and Investigations Subcommittee. She is also a new grandmother who understands the sense of panic and urgency gripping parents.
Weiterlesen »
U.S. FDA declines to authorize Verrica's viral skin disease treatmentThe U.S. Food and Drug Administration (FDA) declined to approve Verrica Pharmaceuticals Inc's drug for the treatment of a viral skin disease known as molluscum contagiosum, the company said on Tuesday.
Weiterlesen »